Filing Details
- Accession Number:
- 0001367644-20-000145
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-09-04 20:08:20
- Reporting Period:
- 2020-09-02
- Accepted Time:
- 2020-09-04 20:08:20
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1367644 | Emergent Biosolutions Inc. | EBS | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1193522 | W Louis Sullivan | 400 Professional Dr, Suite 400 Gaithersburg MD 20879 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-09-02 | 20,525 | $111.22 | 42,762 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2020-09-02 | 7,893 | $20.08 | 50,655 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-09-02 | 7,893 | $111.23 | 42,762 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Options (Right to Buy) | Acquisiton | 2020-09-02 | 7,893 | $0.00 | 7,893 | $20.08 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
15,786 | 2021-05-19 | No | 4 | M | Direct |
Footnotes
- Consists of previously exercised options granted under the company's stock incentive plan as amended and restated.
- The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices between $110.96 and $111.40.
- Consists of an option granted under the company's stock incentive plan as amended and restated.
- The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices between $110.96 and $111.32.
- The option grant is fully vested.